切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2014, Vol. 03 ›› Issue (03) : 190 -192. doi: 10.3877/cma.j.issn.2095-3259.2014.03.010

所属专题: 文献

专家论坛

产后溶血性尿毒症综合征
王晨虹1,()   
  1. 1. 518028 深圳,南方医科大学附属深圳妇幼保健院产科
  • 收稿日期:2014-05-04 出版日期:2014-08-18
  • 通信作者: 王晨虹

Postpartum hemolytic uremic syndrome

Chenhong Wang1()   

  • Received:2014-05-04 Published:2014-08-18
  • Corresponding author: Chenhong Wang
引用本文:

王晨虹. 产后溶血性尿毒症综合征[J]. 中华产科急救电子杂志, 2014, 03(03): 190-192.

Chenhong Wang. Postpartum hemolytic uremic syndrome[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2014, 03(03): 190-192.

产后溶血性尿毒症综合征是非典型溶血性尿毒症综合征的一种,临床表现为产后至10周发生的急性肾功能衰竭伴血小板减少和微血管性贫血,临床罕见,病死率高。文中就该病的发病因素、病理机制、诊断要点、鉴别诊断、一般处理、产科处理及疾病的预后进行讨论。

Postpartum hemolytic uremic syndrome (PHUS) is one of the atypical hemolytic uremic syndrome. Clinical manifestation of PHUS is acute kidney failure, with thrombocytopenia and microangiopathic hemolytic anemia during postpartum to 10 weeks postpartum. It is rare, but mortality is high. This article discusses the definition, pathogenesis, pathomechanism, diagnosis, differential diagnosis, general treatment, obstetric treatment and the prognosis of PHUS.

[1]
Kavanagh D, Richards A, Atkinson J. Complement regulatory genes and hemolytic uremic syndromes[J]. Annu Rev Med, 2008, 59:293-309.
[2]
Amrit K, Larissa K. Haemolytic uraemic syndrome[J]. Paediatrics and Child Health, 2012, 22(8):364-368.
[3]
Michael M, Elliott EJ, Craig JC, et al. Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura:a systematic review of randomized controlled trials[J]. Am J Kidney Dis, 2009, 53(2):259-272.
[4]
Noris M, Remuzzi G. Disease of the month:hemolytic uremic syndrome[J]. J Am Soc Nephrol, 2005, 16(4):1035-1050.
[5]
Chen YC, Chen HS, Shen CJ, et al. Delayed postpartum hemorrhage-a rare clinical presentation of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome :a case report[J]. Kaohsiung J Med Sci, 2005, 21(11):532-535.
[6]
张海斌,袁伟杰. 溶血性尿毒症综合征的研究进展[J]. 国外医学泌尿系统分册,1999, 19(4):171-1751.
[7]
George JN. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome[J]. Curr Opin Hematol, 2003, 10 (5):339-3441.
[8]
徐翠清,于风华,宗保娥,等. 产后溶血性尿毒症综合征研究进展[J]. 实用妇产科杂志,2006, 22(10):595-598.
[9]
Iannuzzi M, Siconolfi P, D′Angelillo A, et al. A post-partum hemolytic-uremic-like-syndrome in a patient with preeclampsia: description of a clinical case[J]. Transfus Apher Sci, 2006, 34 (1):11-141.
[10]
Anacleto FE, Cifra CL, Elises JS. Postpartum hemolytic uremic syndrome in a 17-year-old Filipina primigravid[J]. Pediatr Nephrol, 2003, 18 (12):1283-1285.
[11]
姜保慧,李新兵,梁登辉,等. 早期碱化尿液治疗产后溶血性尿毒症综合征的疗效观察[J/CD]. 中华妇幼临床医学杂志(电子版), 2013, 9(4):458-459.
[12]
Ariceta G, Arrizabalaga B, Aguirre M, et al. Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants[J]. Am J Kidney Dis, 2012, 59(5):707-710.
[13]
Dorresteijn EM, van de Kar NC, Cransberg K. Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count[J]. Pediatr Nephrol, 2012, 27(7):1193-1195.
[14]
Kim JJ, Waller SC, Reid CJ. Eculizumab in atypical haemolytic uraemic syndrome allows cessation of plasma exchange and dialysis[J]. Clin Kidney J, 2012, 5(5):34-36.
[15]
Garjau M. Early treatment with eculizumab may be beneficial in atypical haemolytic uraemic syndrome[J]. Clin Kidney J, 2012, 5(2):31-33.
[16]
Lampinen K, Pehonen S, Pettila V, et al. Treatment of postpartum thrombotic microangiopathy with plasma exchange using cryosupematant as replacement[J]. Acta Obstet Gynecol Scand, 2004, 83(2):175-179.
[17]
Lampinen K, Peltonen S, Pettila V, et al. Treatment of postpartum thrombotic microangiopathy with plasma exchange using cryosupematant as replacement[J]. Acta Obstet Gynecol Scand, 2004, 83(2):175-179.
[18]
Michael M, Elliott EJ, Craig JC, et al. Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura:a systematic review of randomized controlled trials[J]. Am J Kidney Dis, 2009, 53(2):259-272.
[19]
梅长林,叶朝阳,戎殳,等. 实用透析手册[M].2版.北京:人民卫生出版社,2009:149-177.
[20]
McCrae KR, Cines DB. Thrombotic microangiopathy during pregnancy[J]. Semin Hematol, 1997, 34(3):148-154.
[21]
Bosch T, Wendler T. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review[J]. Ther Apher, 2001, 5(3):182-185.
[22]
Dashe JS, Ramin SM, Cunningham FG. The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy[J]. Obstet Gynecol, 1998, 91(5 Pt 1):662-668.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[3] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[4] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[5] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[6] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[7] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[8] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[9] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[10] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[11] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[12] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[13] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[14] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
[15] 周婷, 孙培培, 张二明, 安欣华, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(07): 790-797.
阅读次数
全文


摘要